Lv12
38 积分 2024-12-30 加入
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
20小时前
已完结
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
5天前
已完结
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
5天前
已完结
Unexplained or Refractory Chronic Cough in Adults
6天前
已完结
Targeted alpha therapy (r)evolution: emerging nuclides for clinical applications
7天前
已完结
Airway sensory neurobiology and TRP channels in chronic cough: mechanisms, cough hypersensitivity, and therapeutic translation
8天前
已关闭
A Novel Charged Sodium-Channel Blocker, Ntx-1175, Is Effective In Reducing Acute Visceral Hypersensitivity In Vivo
13天前
已完结
Target identification and assessment in the era of AI
18天前
已完结
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
19天前
已完结
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
21天前
已完结
皖公网安备34019202002308
